nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—Tamoxifen—pancreatic cancer	0.115	0.138	CbGbCtD
Tranylcypromine—CYP2E1—Dacarbazine—pancreatic cancer	0.0955	0.114	CbGbCtD
Tranylcypromine—CYP2A6—Fluorouracil—pancreatic cancer	0.0848	0.102	CbGbCtD
Tranylcypromine—CYP2E1—Tamoxifen—pancreatic cancer	0.0759	0.091	CbGbCtD
Tranylcypromine—CYP1A2—Dacarbazine—pancreatic cancer	0.0552	0.0662	CbGbCtD
Tranylcypromine—CYP2C19—Tamoxifen—pancreatic cancer	0.0476	0.057	CbGbCtD
Tranylcypromine—CYP1A2—Tamoxifen—pancreatic cancer	0.0439	0.0526	CbGbCtD
Tranylcypromine—CYP2C9—Tamoxifen—pancreatic cancer	0.0396	0.0474	CbGbCtD
Tranylcypromine—CYP1A2—Erlotinib—pancreatic cancer	0.0373	0.0448	CbGbCtD
Tranylcypromine—CYP2D6—Tamoxifen—pancreatic cancer	0.0362	0.0434	CbGbCtD
Tranylcypromine—CYP1A2—Fluorouracil—pancreatic cancer	0.0324	0.0388	CbGbCtD
Tranylcypromine—CYP2D6—Erlotinib—pancreatic cancer	0.0308	0.0369	CbGbCtD
Tranylcypromine—CYP2C9—Fluorouracil—pancreatic cancer	0.0292	0.035	CbGbCtD
Tranylcypromine—CYP3A4—Tamoxifen—pancreatic cancer	0.023	0.0276	CbGbCtD
Tranylcypromine—CYP3A4—Erlotinib—pancreatic cancer	0.0196	0.0235	CbGbCtD
Tranylcypromine—CYP3A4—Irinotecan—pancreatic cancer	0.0177	0.0212	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—pancreatic cancer	0.0152	0.0182	CbGbCtD
Tranylcypromine—CYP3A4—Docetaxel—pancreatic cancer	0.0129	0.0155	CbGbCtD
Tranylcypromine—CYP3A4—Sunitinib—pancreatic cancer	0.0129	0.0154	CbGbCtD
Tranylcypromine—CYP3A4—Doxorubicin—pancreatic cancer	0.00965	0.0116	CbGbCtD
Tranylcypromine—Insomnia—Sunitinib—pancreatic cancer	0.000516	0.00311	CcSEcCtD
Tranylcypromine—Leukopenia—Irinotecan—pancreatic cancer	0.000515	0.00311	CcSEcCtD
Tranylcypromine—Paraesthesia—Sunitinib—pancreatic cancer	0.000512	0.00309	CcSEcCtD
Tranylcypromine—Anaemia—Fluorouracil—pancreatic cancer	0.000509	0.00308	CcSEcCtD
Tranylcypromine—Loss of consciousness—Irinotecan—pancreatic cancer	0.000506	0.00305	CcSEcCtD
Tranylcypromine—Leukopenia—Gemcitabine—pancreatic cancer	0.000502	0.00303	CcSEcCtD
Tranylcypromine—Hypertension—Irinotecan—pancreatic cancer	0.000497	0.003	CcSEcCtD
Tranylcypromine—Decreased appetite—Sunitinib—pancreatic cancer	0.000496	0.00299	CcSEcCtD
Tranylcypromine—Leukopenia—Fluorouracil—pancreatic cancer	0.000493	0.00298	CcSEcCtD
Tranylcypromine—Pain—Sunitinib—pancreatic cancer	0.000488	0.00294	CcSEcCtD
Tranylcypromine—Constipation—Sunitinib—pancreatic cancer	0.000488	0.00294	CcSEcCtD
Tranylcypromine—Hypertension—Gemcitabine—pancreatic cancer	0.000484	0.00292	CcSEcCtD
Tranylcypromine—Asthenia—Tamoxifen—pancreatic cancer	0.000478	0.00288	CcSEcCtD
Tranylcypromine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000475	0.00287	CcSEcCtD
Tranylcypromine—Confusional state—Irinotecan—pancreatic cancer	0.000474	0.00286	CcSEcCtD
Tranylcypromine—Asthenia—Erlotinib—pancreatic cancer	0.000473	0.00285	CcSEcCtD
Tranylcypromine—Oedema—Irinotecan—pancreatic cancer	0.00047	0.00284	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000466	0.00282	CcSEcCtD
Tranylcypromine—Shock—Irinotecan—pancreatic cancer	0.000462	0.00279	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00046	0.00278	CcSEcCtD
Tranylcypromine—Haemoglobin—Docetaxel—pancreatic cancer	0.000459	0.00277	CcSEcCtD
Tranylcypromine—Oedema—Gemcitabine—pancreatic cancer	0.000458	0.00276	CcSEcCtD
Tranylcypromine—Haemorrhage—Docetaxel—pancreatic cancer	0.000457	0.00276	CcSEcCtD
Tranylcypromine—Hepatitis—Docetaxel—pancreatic cancer	0.000457	0.00276	CcSEcCtD
Tranylcypromine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000456	0.00275	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000455	0.00275	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000454	0.00274	CcSEcCtD
Tranylcypromine—Confusional state—Fluorouracil—pancreatic cancer	0.000454	0.00274	CcSEcCtD
Tranylcypromine—Body temperature increased—Sunitinib—pancreatic cancer	0.000451	0.00272	CcSEcCtD
Tranylcypromine—Abdominal pain—Sunitinib—pancreatic cancer	0.000451	0.00272	CcSEcCtD
Tranylcypromine—Diarrhoea—Erlotinib—pancreatic cancer	0.000451	0.00272	CcSEcCtD
Tranylcypromine—Oedema—Fluorouracil—pancreatic cancer	0.00045	0.00272	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000448	0.0027	CcSEcCtD
Tranylcypromine—Anorexia—Irinotecan—pancreatic cancer	0.000448	0.0027	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000442	0.00267	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00044	0.00266	CcSEcCtD
Tranylcypromine—Dizziness—Tamoxifen—pancreatic cancer	0.00044	0.00266	CcSEcCtD
Tranylcypromine—Tachycardia—Fluorouracil—pancreatic cancer	0.000439	0.00265	CcSEcCtD
Tranylcypromine—Hypotension—Irinotecan—pancreatic cancer	0.000439	0.00265	CcSEcCtD
Tranylcypromine—Anorexia—Gemcitabine—pancreatic cancer	0.000436	0.00263	CcSEcCtD
Tranylcypromine—Dizziness—Erlotinib—pancreatic cancer	0.000436	0.00263	CcSEcCtD
Tranylcypromine—Anorexia—Fluorouracil—pancreatic cancer	0.000429	0.00259	CcSEcCtD
Tranylcypromine—Hypotension—Gemcitabine—pancreatic cancer	0.000428	0.00258	CcSEcCtD
Tranylcypromine—Insomnia—Irinotecan—pancreatic cancer	0.000425	0.00256	CcSEcCtD
Tranylcypromine—Flushing—Docetaxel—pancreatic cancer	0.000424	0.00256	CcSEcCtD
Tranylcypromine—Vomiting—Tamoxifen—pancreatic cancer	0.000423	0.00256	CcSEcCtD
Tranylcypromine—Paraesthesia—Irinotecan—pancreatic cancer	0.000422	0.00255	CcSEcCtD
Tranylcypromine—Hypotension—Fluorouracil—pancreatic cancer	0.00042	0.00254	CcSEcCtD
Tranylcypromine—Rash—Tamoxifen—pancreatic cancer	0.00042	0.00253	CcSEcCtD
Tranylcypromine—Dermatitis—Tamoxifen—pancreatic cancer	0.000419	0.00253	CcSEcCtD
Tranylcypromine—Ataxia—Epirubicin—pancreatic cancer	0.000419	0.00253	CcSEcCtD
Tranylcypromine—Vomiting—Erlotinib—pancreatic cancer	0.000419	0.00253	CcSEcCtD
Tranylcypromine—Somnolence—Irinotecan—pancreatic cancer	0.000418	0.00252	CcSEcCtD
Tranylcypromine—Headache—Tamoxifen—pancreatic cancer	0.000417	0.00252	CcSEcCtD
Tranylcypromine—Rash—Erlotinib—pancreatic cancer	0.000415	0.00251	CcSEcCtD
Tranylcypromine—Dermatitis—Erlotinib—pancreatic cancer	0.000415	0.00251	CcSEcCtD
Tranylcypromine—Insomnia—Gemcitabine—pancreatic cancer	0.000414	0.0025	CcSEcCtD
Tranylcypromine—Headache—Erlotinib—pancreatic cancer	0.000413	0.00249	CcSEcCtD
Tranylcypromine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000411	0.00248	CcSEcCtD
Tranylcypromine—Chills—Docetaxel—pancreatic cancer	0.00041	0.00248	CcSEcCtD
Tranylcypromine—Asthenia—Sunitinib—pancreatic cancer	0.000409	0.00247	CcSEcCtD
Tranylcypromine—Decreased appetite—Irinotecan—pancreatic cancer	0.000408	0.00247	CcSEcCtD
Tranylcypromine—Insomnia—Fluorouracil—pancreatic cancer	0.000407	0.00246	CcSEcCtD
Tranylcypromine—Somnolence—Gemcitabine—pancreatic cancer	0.000407	0.00246	CcSEcCtD
Tranylcypromine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000404	0.00244	CcSEcCtD
Tranylcypromine—Alopecia—Docetaxel—pancreatic cancer	0.000404	0.00244	CcSEcCtD
Tranylcypromine—Constipation—Irinotecan—pancreatic cancer	0.000402	0.00242	CcSEcCtD
Tranylcypromine—Pain—Irinotecan—pancreatic cancer	0.000402	0.00242	CcSEcCtD
Tranylcypromine—Somnolence—Fluorouracil—pancreatic cancer	0.0004	0.00241	CcSEcCtD
Tranylcypromine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000398	0.0024	CcSEcCtD
Tranylcypromine—Nausea—Tamoxifen—pancreatic cancer	0.000395	0.00239	CcSEcCtD
Tranylcypromine—Pain—Gemcitabine—pancreatic cancer	0.000391	0.00236	CcSEcCtD
Tranylcypromine—Constipation—Gemcitabine—pancreatic cancer	0.000391	0.00236	CcSEcCtD
Tranylcypromine—Nausea—Erlotinib—pancreatic cancer	0.000391	0.00236	CcSEcCtD
Tranylcypromine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000391	0.00236	CcSEcCtD
Tranylcypromine—Diarrhoea—Sunitinib—pancreatic cancer	0.00039	0.00236	CcSEcCtD
Tranylcypromine—Ataxia—Doxorubicin—pancreatic cancer	0.000388	0.00234	CcSEcCtD
Tranylcypromine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000387	0.00234	CcSEcCtD
Tranylcypromine—Pain—Fluorouracil—pancreatic cancer	0.000385	0.00232	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000384	0.00232	CcSEcCtD
Tranylcypromine—Muscle spasms—Docetaxel—pancreatic cancer	0.000382	0.00231	CcSEcCtD
Tranylcypromine—Dizziness—Sunitinib—pancreatic cancer	0.000377	0.00228	CcSEcCtD
Tranylcypromine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000377	0.00228	CcSEcCtD
Tranylcypromine—Abdominal pain—Irinotecan—pancreatic cancer	0.000371	0.00224	CcSEcCtD
Tranylcypromine—Body temperature increased—Irinotecan—pancreatic cancer	0.000371	0.00224	CcSEcCtD
Tranylcypromine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000371	0.00224	CcSEcCtD
Tranylcypromine—Anaemia—Docetaxel—pancreatic cancer	0.000368	0.00222	CcSEcCtD
Tranylcypromine—Vomiting—Sunitinib—pancreatic cancer	0.000363	0.00219	CcSEcCtD
Tranylcypromine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000362	0.00218	CcSEcCtD
Tranylcypromine—Rash—Sunitinib—pancreatic cancer	0.00036	0.00217	CcSEcCtD
Tranylcypromine—Dermatitis—Sunitinib—pancreatic cancer	0.000359	0.00217	CcSEcCtD
Tranylcypromine—Urticaria—Fluorouracil—pancreatic cancer	0.000357	0.00216	CcSEcCtD
Tranylcypromine—Headache—Sunitinib—pancreatic cancer	0.000357	0.00216	CcSEcCtD
Tranylcypromine—Syncope—Docetaxel—pancreatic cancer	0.000357	0.00215	CcSEcCtD
Tranylcypromine—Leukopenia—Docetaxel—pancreatic cancer	0.000356	0.00215	CcSEcCtD
Tranylcypromine—Pollakiuria—Epirubicin—pancreatic cancer	0.000356	0.00215	CcSEcCtD
Tranylcypromine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000356	0.00215	CcSEcCtD
Tranylcypromine—Palpitations—Docetaxel—pancreatic cancer	0.000352	0.00212	CcSEcCtD
Tranylcypromine—Loss of consciousness—Docetaxel—pancreatic cancer	0.00035	0.00211	CcSEcCtD
Tranylcypromine—Hypertension—Docetaxel—pancreatic cancer	0.000343	0.00207	CcSEcCtD
Tranylcypromine—Drowsiness—Epirubicin—pancreatic cancer	0.000343	0.00207	CcSEcCtD
Tranylcypromine—Nausea—Sunitinib—pancreatic cancer	0.000339	0.00204	CcSEcCtD
Tranylcypromine—Asthenia—Irinotecan—pancreatic cancer	0.000337	0.00203	CcSEcCtD
Tranylcypromine—Dry mouth—Docetaxel—pancreatic cancer	0.000331	0.002	CcSEcCtD
Tranylcypromine—Sweating—Epirubicin—pancreatic cancer	0.000329	0.00199	CcSEcCtD
Tranylcypromine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000329	0.00199	CcSEcCtD
Tranylcypromine—Asthenia—Gemcitabine—pancreatic cancer	0.000328	0.00198	CcSEcCtD
Tranylcypromine—Confusional state—Docetaxel—pancreatic cancer	0.000327	0.00198	CcSEcCtD
Tranylcypromine—Oedema—Docetaxel—pancreatic cancer	0.000325	0.00196	CcSEcCtD
Tranylcypromine—Diarrhoea—Irinotecan—pancreatic cancer	0.000321	0.00194	CcSEcCtD
Tranylcypromine—Agranulocytosis—Epirubicin—pancreatic cancer	0.00032	0.00193	CcSEcCtD
Tranylcypromine—Shock—Docetaxel—pancreatic cancer	0.000319	0.00193	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000318	0.00192	CcSEcCtD
Tranylcypromine—Drowsiness—Doxorubicin—pancreatic cancer	0.000318	0.00192	CcSEcCtD
Tranylcypromine—Tachycardia—Docetaxel—pancreatic cancer	0.000317	0.00191	CcSEcCtD
Tranylcypromine—Bradycardia—Epirubicin—pancreatic cancer	0.000314	0.00189	CcSEcCtD
Tranylcypromine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000313	0.00189	CcSEcCtD
Tranylcypromine—Dizziness—Irinotecan—pancreatic cancer	0.000311	0.00188	CcSEcCtD
Tranylcypromine—Haemoglobin—Epirubicin—pancreatic cancer	0.00031	0.00187	CcSEcCtD
Tranylcypromine—Anorexia—Docetaxel—pancreatic cancer	0.000309	0.00187	CcSEcCtD
Tranylcypromine—Haemorrhage—Epirubicin—pancreatic cancer	0.000308	0.00186	CcSEcCtD
Tranylcypromine—Hepatitis—Epirubicin—pancreatic cancer	0.000308	0.00186	CcSEcCtD
Tranylcypromine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000308	0.00186	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000307	0.00185	CcSEcCtD
Tranylcypromine—Sweating—Doxorubicin—pancreatic cancer	0.000305	0.00184	CcSEcCtD
Tranylcypromine—Hypotension—Docetaxel—pancreatic cancer	0.000303	0.00183	CcSEcCtD
Tranylcypromine—Vomiting—Irinotecan—pancreatic cancer	0.000299	0.0018	CcSEcCtD
Tranylcypromine—Dizziness—Fluorouracil—pancreatic cancer	0.000297	0.0018	CcSEcCtD
Tranylcypromine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000296	0.00179	CcSEcCtD
Tranylcypromine—Rash—Irinotecan—pancreatic cancer	0.000296	0.00179	CcSEcCtD
Tranylcypromine—Dermatitis—Irinotecan—pancreatic cancer	0.000296	0.00179	CcSEcCtD
Tranylcypromine—Headache—Irinotecan—pancreatic cancer	0.000294	0.00178	CcSEcCtD
Tranylcypromine—Insomnia—Docetaxel—pancreatic cancer	0.000294	0.00177	CcSEcCtD
Tranylcypromine—Paraesthesia—Docetaxel—pancreatic cancer	0.000292	0.00176	CcSEcCtD
Tranylcypromine—Vomiting—Gemcitabine—pancreatic cancer	0.000291	0.00176	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—pancreatic cancer	0.00029	0.00175	CcSEcCtD
Tranylcypromine—Somnolence—Docetaxel—pancreatic cancer	0.000289	0.00174	CcSEcCtD
Tranylcypromine—Rash—Gemcitabine—pancreatic cancer	0.000288	0.00174	CcSEcCtD
Tranylcypromine—Dermatitis—Gemcitabine—pancreatic cancer	0.000288	0.00174	CcSEcCtD
Tranylcypromine—Tinnitus—Epirubicin—pancreatic cancer	0.000287	0.00174	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000287	0.00173	CcSEcCtD
Tranylcypromine—Headache—Gemcitabine—pancreatic cancer	0.000287	0.00173	CcSEcCtD
Tranylcypromine—Flushing—Epirubicin—pancreatic cancer	0.000286	0.00173	CcSEcCtD
Tranylcypromine—Vomiting—Fluorouracil—pancreatic cancer	0.000286	0.00173	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000285	0.00172	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—pancreatic cancer	0.000285	0.00172	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000284	0.00171	CcSEcCtD
Tranylcypromine—Rash—Fluorouracil—pancreatic cancer	0.000284	0.00171	CcSEcCtD
Tranylcypromine—Dermatitis—Fluorouracil—pancreatic cancer	0.000283	0.00171	CcSEcCtD
Tranylcypromine—Decreased appetite—Docetaxel—pancreatic cancer	0.000282	0.0017	CcSEcCtD
Tranylcypromine—Headache—Fluorouracil—pancreatic cancer	0.000282	0.0017	CcSEcCtD
Tranylcypromine—Nausea—Irinotecan—pancreatic cancer	0.000279	0.00168	CcSEcCtD
Tranylcypromine—Pain—Docetaxel—pancreatic cancer	0.000278	0.00168	CcSEcCtD
Tranylcypromine—Constipation—Docetaxel—pancreatic cancer	0.000278	0.00168	CcSEcCtD
Tranylcypromine—Chills—Epirubicin—pancreatic cancer	0.000277	0.00167	CcSEcCtD
Tranylcypromine—Alopecia—Epirubicin—pancreatic cancer	0.000272	0.00164	CcSEcCtD
Tranylcypromine—Nausea—Gemcitabine—pancreatic cancer	0.000272	0.00164	CcSEcCtD
Tranylcypromine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000268	0.00162	CcSEcCtD
Tranylcypromine—Nausea—Fluorouracil—pancreatic cancer	0.000267	0.00161	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—pancreatic cancer	0.000266	0.00161	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000266	0.0016	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—pancreatic cancer	0.000265	0.0016	CcSEcCtD
Tranylcypromine—Muscle spasms—Epirubicin—pancreatic cancer	0.000258	0.00156	CcSEcCtD
Tranylcypromine—Abdominal pain—Docetaxel—pancreatic cancer	0.000257	0.00155	CcSEcCtD
Tranylcypromine—Body temperature increased—Docetaxel—pancreatic cancer	0.000257	0.00155	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—pancreatic cancer	0.000256	0.00155	CcSEcCtD
Tranylcypromine—Vision blurred—Epirubicin—pancreatic cancer	0.000253	0.00153	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—pancreatic cancer	0.000252	0.00152	CcSEcCtD
Tranylcypromine—Anaemia—Epirubicin—pancreatic cancer	0.000248	0.0015	CcSEcCtD
Tranylcypromine—Agitation—Epirubicin—pancreatic cancer	0.000247	0.00149	CcSEcCtD
Tranylcypromine—Syncope—Epirubicin—pancreatic cancer	0.000241	0.00145	CcSEcCtD
Tranylcypromine—Leukopenia—Epirubicin—pancreatic cancer	0.00024	0.00145	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000239	0.00144	CcSEcCtD
Tranylcypromine—Palpitations—Epirubicin—pancreatic cancer	0.000237	0.00143	CcSEcCtD
Tranylcypromine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000236	0.00142	CcSEcCtD
Tranylcypromine—Vision blurred—Doxorubicin—pancreatic cancer	0.000234	0.00141	CcSEcCtD
Tranylcypromine—Asthenia—Docetaxel—pancreatic cancer	0.000233	0.00141	CcSEcCtD
Tranylcypromine—Hypertension—Epirubicin—pancreatic cancer	0.000232	0.0014	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—pancreatic cancer	0.000229	0.00139	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—pancreatic cancer	0.000228	0.00138	CcSEcCtD
Tranylcypromine—Anxiety—Epirubicin—pancreatic cancer	0.000228	0.00137	CcSEcCtD
Tranylcypromine—Dry mouth—Epirubicin—pancreatic cancer	0.000223	0.00135	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—pancreatic cancer	0.000223	0.00134	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—pancreatic cancer	0.000222	0.00134	CcSEcCtD
Tranylcypromine—Diarrhoea—Docetaxel—pancreatic cancer	0.000222	0.00134	CcSEcCtD
Tranylcypromine—Confusional state—Epirubicin—pancreatic cancer	0.000221	0.00133	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—pancreatic cancer	0.000219	0.00132	CcSEcCtD
Tranylcypromine—Oedema—Epirubicin—pancreatic cancer	0.000219	0.00132	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000218	0.00132	CcSEcCtD
Tranylcypromine—Shock—Epirubicin—pancreatic cancer	0.000215	0.0013	CcSEcCtD
Tranylcypromine—Dizziness—Docetaxel—pancreatic cancer	0.000215	0.0013	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000214	0.00129	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—pancreatic cancer	0.000214	0.00129	CcSEcCtD
Tranylcypromine—Tachycardia—Epirubicin—pancreatic cancer	0.000214	0.00129	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000212	0.00128	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—pancreatic cancer	0.000211	0.00127	CcSEcCtD
Tranylcypromine—Anorexia—Epirubicin—pancreatic cancer	0.000209	0.00126	CcSEcCtD
Tranylcypromine—Dry mouth—Doxorubicin—pancreatic cancer	0.000207	0.00125	CcSEcCtD
Tranylcypromine—Vomiting—Docetaxel—pancreatic cancer	0.000206	0.00125	CcSEcCtD
Tranylcypromine—Rash—Docetaxel—pancreatic cancer	0.000205	0.00124	CcSEcCtD
Tranylcypromine—Hypotension—Epirubicin—pancreatic cancer	0.000205	0.00124	CcSEcCtD
Tranylcypromine—Dermatitis—Docetaxel—pancreatic cancer	0.000205	0.00123	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—pancreatic cancer	0.000204	0.00123	CcSEcCtD
Tranylcypromine—Headache—Docetaxel—pancreatic cancer	0.000203	0.00123	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—pancreatic cancer	0.000203	0.00122	CcSEcCtD
Tranylcypromine—Shock—Doxorubicin—pancreatic cancer	0.000199	0.0012	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000198	0.0012	CcSEcCtD
Tranylcypromine—Insomnia—Epirubicin—pancreatic cancer	0.000198	0.0012	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—pancreatic cancer	0.000198	0.00119	CcSEcCtD
Tranylcypromine—Paraesthesia—Epirubicin—pancreatic cancer	0.000197	0.00119	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000196	0.00118	CcSEcCtD
Tranylcypromine—Somnolence—Epirubicin—pancreatic cancer	0.000195	0.00118	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—pancreatic cancer	0.000193	0.00117	CcSEcCtD
Tranylcypromine—Nausea—Docetaxel—pancreatic cancer	0.000193	0.00116	CcSEcCtD
Tranylcypromine—Decreased appetite—Epirubicin—pancreatic cancer	0.00019	0.00115	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—pancreatic cancer	0.000189	0.00114	CcSEcCtD
Tranylcypromine—Pain—Epirubicin—pancreatic cancer	0.000187	0.00113	CcSEcCtD
Tranylcypromine—Constipation—Epirubicin—pancreatic cancer	0.000187	0.00113	CcSEcCtD
Tranylcypromine—Insomnia—Doxorubicin—pancreatic cancer	0.000183	0.00111	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000182	0.0011	CcSEcCtD
Tranylcypromine—Feeling abnormal—Epirubicin—pancreatic cancer	0.00018	0.00109	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—pancreatic cancer	0.00018	0.00109	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000179	0.00108	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000176	0.00106	CcSEcCtD
Tranylcypromine—Urticaria—Epirubicin—pancreatic cancer	0.000174	0.00105	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—pancreatic cancer	0.000173	0.00105	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—pancreatic cancer	0.000173	0.00105	CcSEcCtD
Tranylcypromine—Body temperature increased—Epirubicin—pancreatic cancer	0.000173	0.00105	CcSEcCtD
Tranylcypromine—Abdominal pain—Epirubicin—pancreatic cancer	0.000173	0.00105	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000167	0.00101	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000166	0.001	CcSEcCtD
Tranylcypromine—Urticaria—Doxorubicin—pancreatic cancer	0.000161	0.000972	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—pancreatic cancer	0.00016	0.000967	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—pancreatic cancer	0.00016	0.000967	CcSEcCtD
Tranylcypromine—Asthenia—Epirubicin—pancreatic cancer	0.000157	0.000949	CcSEcCtD
Tranylcypromine—Diarrhoea—Epirubicin—pancreatic cancer	0.00015	0.000905	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—pancreatic cancer	0.000145	0.000878	CcSEcCtD
Tranylcypromine—Dizziness—Epirubicin—pancreatic cancer	0.000145	0.000874	CcSEcCtD
Tranylcypromine—Vomiting—Epirubicin—pancreatic cancer	0.000139	0.000841	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000139	0.000837	CcSEcCtD
Tranylcypromine—Rash—Epirubicin—pancreatic cancer	0.000138	0.000834	CcSEcCtD
Tranylcypromine—Dermatitis—Epirubicin—pancreatic cancer	0.000138	0.000833	CcSEcCtD
Tranylcypromine—Headache—Epirubicin—pancreatic cancer	0.000137	0.000828	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—pancreatic cancer	0.000134	0.000809	CcSEcCtD
Tranylcypromine—Nausea—Epirubicin—pancreatic cancer	0.00013	0.000785	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—pancreatic cancer	0.000129	0.000778	CcSEcCtD
Tranylcypromine—Rash—Doxorubicin—pancreatic cancer	0.000128	0.000771	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—pancreatic cancer	0.000128	0.000771	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—pancreatic cancer	0.000127	0.000766	CcSEcCtD
Tranylcypromine—Nausea—Doxorubicin—pancreatic cancer	0.00012	0.000727	CcSEcCtD
